Australia markets closed

Oscar Health, Inc. (OSCR)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
15.82+0.50 (+3.26%)
At close: 04:00PM EDT
15.61 -0.21 (-1.33%)
After hours: 07:31PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 3.75B
Enterprise value 1.82B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.58
Price/book (mrq)3.64
Enterprise value/revenue 0.28
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.61
52-week change 3110.37%
S&P500 52-week change 318.96%
52-week high 323.44
52-week low 34.72
50-day moving average 318.31
200-day moving average 313.49

Share statistics

Avg vol (3-month) 33.45M
Avg vol (10-day) 32.69M
Shares outstanding 5201.71M
Implied shares outstanding 6237.22M
Float 8180.46M
% held by insiders 12.65%
% held by institutions 179.29%
Shares short (15 July 2024) 414.38M
Short ratio (15 July 2024) 44.09
Short % of float (15 July 2024) 47.46%
Short % of shares outstanding (15 July 2024) 46.06%
Shares short (prior month 14 June 2024) 411.64M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -0.82%
Operating margin (ttm)8.66%

Management effectiveness

Return on assets (ttm)-0.35%
Return on equity (ttm)-5.44%

Income statement

Revenue (ttm)6.53B
Revenue per share (ttm)29.00
Quarterly revenue growth (yoy)45.80%
Gross profit (ttm)N/A
EBITDA 8.87M
Net income avi to common (ttm)-53.59M
Diluted EPS (ttm)-0.42
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.85B
Total cash per share (mrq)12.02
Total debt (mrq)365.14M
Total debt/equity (mrq)35.30%
Current ratio (mrq)1.16
Book value per share (mrq)4.38

Cash flow statement

Operating cash flow (ttm)-52.51M
Levered free cash flow (ttm)687.21M